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Background: Aging is almost assocaited with inner ear disorders (InEarDs) 
by means of age-related hearing impairment (ARHI) or vertigo-and-
dizziness as well as the carotid artery disease requiring revascularization 
(CAD-R). Objective: The present study aimed to study the prevalence 
and characteristics of InEarDs in older adults diagnosed with CAD-R. The 
other aim was to determine if InEarDs in CAD-R patients is age-related or 
might be explained by a concomitant CAD-R. Method: A retrospective, 
case-control study was conducted at the Mayo Clinic, Florida. The 
study cohort includes 919 patients who had CAD-R. The control group 
consisted of 244 age- and gender-matched patients presenting with 
cardiac or peripheral artery disease. The InEarDs were assessed based on 
the diagnosis upon presentation to the Audiology Clinic and follow-up. 
Results: Of the 919, 348 had ARHI that includes significant peripheral 
signs and central symptoms (24.9%), vertigo-and-dizziness events that are 
recurrent and persistent with normal objective vestibular testing (12.9%), or 
a combination of both (11.0%). These percentages were significantly higher 
in the study group relative to the control group. After adjustment for the 
vascular risk factors, the study group had significantly higher odds of ARHI 
(OR= 1.94; 95% CI: 1.09-3.44; P<0.05). Conclusion: CAD-R patients had 
significantly higher InEarDs than the control group. CAD-R is more likely 
to be associated with ARHI rather than the vertigo-and-dizziness even after 
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1. Introduction
Atherosclerosis that predisposes carotid artery disease requiring revascularization (CAD-R) is a chronic inflammation process associated with 
conventional risk factors; these include age, gender, smok-
ing, hyperlipidemia, hypertension, genetic, diabetes, and 
cardiovascular events [1-7]. Treatment options for CAD-R 
include the following: medical therapy and carotid endar-
terectomy (CEA), with a primary goal to prevent cerebro-
vascular events (strokes) or chronic cerebral hypoperfu-
sion that increase risk of mental ill-health (e.g., dementia, 
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depression, cognitive impairment no dementia) [8-13].
Inner ear disorders (InEarDs) by means of age-related 
hearing impairment (ARHI), also known as presbycusis, 
and vertigo-and-dizziness are prevalent in the aging popu-
lation, in which the common vascular risk factors, the as-
sociated disorders, and the cerebrovascular events chronic 
cerebral hypoperfusion found to play a significant role in 
the incidence and progression of ARHI and recurrent, per-
sistent events of vertigo-and-dizziness [14-21] .
The present study aimed to study the prevalence and 
characteristics of InEarDs in older adults diagnosed with 
CAD-R. The other aim was to determine if InEarDs in 




This was a retrospective, case-control cohort study con-
ducted at the Mayo Clinic, Florida, and approved by the 
Institutional Review Board.  The study cohort includes 
919 patients who had CAD requiring revascularization. 
Revascularization carried out between December 1, 1995, 
and June 30, 2016. The control group consisted of 244 
age-matched patients who diagnosed with cardiac or 
peripheral artery disease between January 1, 2014, and 
December 31, 2017.  The InEarDs were assessed based on 
the diagnosis upon presentation to the Audiology Clinic 
and follow-up.  The selection criteria of the patient sample 
and the grouping of InEarDs are listed in the Figure 1.
Figure 1. The selection criteria of the patient sample
2.2 Analysis of Results 
All analyses were performed using SPSS version 25 
(SPSS, Inc, an IBM Company, Chicago, Ilinois) and re-
viewed by a statistician at the Mayo Clinic, Florida. De-
scriptive statistics for quantitative variables are presented 
as prevalence. The Chi-square test was used to evaluate 
the preoperative characteristics difference in each group. 
Logistic regression was performed to assess the associa-
tion of identified inner ear disorders with CAD-R. 
3. Results
3.1 Demographic Data
The baseline characteristics of the study and control 
groups are shown in Table 1. A non- significant differenc-
es (P>.05) in age, sex, diabetes mellitus, and hypertension 
were noted between the two groups. Howevere, a substan-
DOI: https://doi.org/10.30564/jgm.v2i3.2385
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tial difference (P<.001) in dyslipidemia and cardiovascu-
lar events were noted. 
The reported degree of stenosis of the common carotid 
artery on the surgical site at the time of operation in the 
carotid group was as follows: more than 70% to 99% in 
96.6%, less than 50% to 69% in 2.94%, less than 50% in 
0.22%, and occluded in 0.22%. Eight hundred and eighty-
eight of patients in the carotid group had carotid stenosis 
of more than 70% to 99% in the surgical site, based on ul-
trasonography and computed tomography. In comparison, 
61 of patients in the carotid group had stenosis of more 
than 50% in the non-surgical side. All patients in the study 
group were under the lipid-lowering treatment, 80% under 
antihypertensive therapy, and 75% under antiplatelet ther-
apy. Carotid endarterectomy with cerebral protection was 
the surgical procedure for all the carotid subjects. 
Relative to the control group, the study group had sig-
nificantly (P<0.001) a higher percentage of ARHI [229 
(24.9%)] or recurrent, persistent vertigo-and-dizziness 
[119 (12.9%)] or a combination of both [100 (11.0%)]. 
Percentages were presented in Tables 2 and 3. 
Table 1. Characteristics of Study Groups (CAD-R)
Variable Carotid Group(n=919), No. (%)
Control Group
(n=244), No. (%) P-Value
Mean (SD) age, y 81.7 (8.90) 80.7 (4.72) >.05
Sex
>.05Male 592 (64.4) 142 (58.2)
Female 327 (35.6) 102 (41.8)
Degree of carotid stenosis in the surgical side, %
<50 2 (0.22) NA
<50-69 27 (2.94) NA
>70-99 888 (96.6) NA
Occluded 2 (0.22) NA
Degree of carotid stenosis in the non-surgical side, %
<50 636 (69.2) NA
<50-69 179 (19.4) NA
>70-99 61 (6.6) NA
Occluded 43 (4.0) NA
Associated risk factors and related disorders
Hypertension 736 (80.1) 202 (82.8) > .05
Hyperlipidemia 725 (78.9) 164 (67.2) ≤.001
Diabetes mellitusa 220 (23.9) 64 (26.2) >.05
Cardiovascular b 249 (27.1) 89 (36.5) <.001
Notes:
Abbreviation: NA, not applicable (control group did not have stenosis).
a Diabetes mellitus (type 1 or type 2). 
b Cardiovascular (with remote myocardial infarction [more than 6 
months], stable angina, and ejection fraction 25% to 45%).







Mean age, y 81.8 81.8 81.8
Sex
Male 152 (66.3) 74 (62.2) 61 (61.0)
Female 77 (33.6) 45 (37.8) 39 (39.0)
Risk factor and related disorders
Hypertension 191 (83.4) 92 (77.3) 80 (80.0)
Hyperlipidemia 183 (79.9) 97 (81.5) 81 (81.0)
Diabetes mellitus a 57 (24.9) 24 (20.2) 21 (21.0)
Cardiovascular b 62 (27.0) 32 (26.9) 25 (25.0)
Notes:
Abbreviation: NA, not applicable (control group did not have stenosis).
a Diabetes mellitus (type 1 or type 2). 
b Cardiovascular (with remote myocardial infarction [more than 6 
months], stable angina, and ejection fraction 25% to 45%).
Table 3. InEarDs in the Study Groups with a Degree of 
Carotid Stenosis in the Surgical Side 
Variable Carotid Group(n=919), No. (%)
Control Group
(n=244), No. (%) P-Value
ARHI 229 (24.9) 35 (14.3) <.001
Vertigo-and-
Dizziness 119 (12.9) 12 (4.9) <.001
ARHI & Vertigo-and-
Dizziness 100 (10.9) 6 (2.5) <.001
3.2 Characteristics of InEarDs
In the study group, the early- and late-onset of ARHI was 
seen in 54% and 45% based on the revascularization date. 
The onset is often described as a ‘sudden onset of bilateral 
tinnitus followed by hearing changes’ or ‘gradual hearing 
changes.’ Features of central auditory processing deficits - 
i.e., communicative/perceptual difficulties, environmental 
sound detection difficulty, sound localization difficulty, 
and understanding spoken speech in quiet, in noise, over 
distances difficulty - were evident in all patients.  The 
magnitude of ARHI ranged from mild to severe based on 
the audiometric results. The audiometric profile consists 
of high-frequency hearing changes or high- and low-fre-
quency hearing changes. Low-frequency dB hearing level 
was determined as the average decline occurred within 
the range of 0.25, 0.50, and 1 kHz, and high-frequency 
dB hearing level was defined as the average of occurred 
within the range 2, 4, and 8 kHz. The audiometric pattern 
of ARHI in the study group includes significant changes 
in only-high-frequency hearing or high- and low-frequen-
cy hearing [(x2= 6.628, P < 0.01)] relative to the control 
DOI: https://doi.org/10.30564/jgm.v2i3.2385
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group. 
Recurrent positional vertigo, persistent dizziness, im-
balance and fall events with normal objective vestibular 
testing were the commonly observed findings in both 
groups. Recurrent positional vertigo defined as ‘positional 
vertigo that was lasting more than 2 weeks and after at 
least 2 weeks of a symptom-free interval following previ-
ous successful treatments. Persistent defined as ‘dizziness 
and unsteadiness that were lasting 3 months or more’.  In 
the study group, the early- and late-onset (determined 
based on the revascularization date) of these findings was 
seen in 47% and 52%, respectively. A history of peripher-
al vestibular disorders (i.e., benign paroxysmal positional 
vertigo) was reported in some patients in the study group. 
3.3 Logistic Regression
Logistic regression to test the clinical correlate of CAD-R 
with the InEarDs classified to ARHI, vertigo-and-dizzi-
ness, a combination of both was performed. The early 
and late-onset of HI or vertigo-and-dizziness have been 
merged to maintain sufficient statistical power. After ad-
justment for the common risk factors (age, gender, hyper-
tension, hyperlipidemia, diabetes mellitus type 1 or type 2, 
and cardiovascular conditions), the study group had a sig-
nificantly higher Odds of ARHI (OR= 1.94; 95% CI: 1.09-
3.44; P<0.05). The model was statistically significant (β 
= -2.13; SE = .121; Wald = 312.26; P<.001). The overall 
logistic regression model is presented in Table 4.
Table 4. Odds Ratios in the Study Group Compared With 
Control Group After Adjustment for Risk Factors
CAROTID STENOSIS
Predictor Odds Ratio (95% CI) P-Value
Age 0.97 (0.94-1.00) >.05
Sex 1.55 (0.91-2.62) >.05
Hyperlipidemia 1.67 (0.914-3.04) >.05
Hypertension 0.82 (0.31-0.12) <.05
Diabetes mellitus a 1.56 (0.82-2.98) >.05
Cardiovascular disease b 0.90 (1.09-2.96) >.05
ARHI 1.94 (1.09-3.44) <.05
Notes:
a  Diabetes mellitus (type 1 or type 2). 
b Cardiovascular (with remote myocardial infarction [more than 6 
months], stable angina, and ejection fraction 25% to 45%).
4. Discussion
The present study aimed to study the prevalence and 
characteristics of InEarDs in older adults diagnosed with 
CAD-R. The other aim was to determine if InEarDs in 
CAD-R patients is age-related or might be explained by 
a concomitant CAD-R. In age-matched groups, CAD-R 
patients had higher percentages of ARHI, vertigo-and-diz-
ziness, a combination of both. These percentages were 
significantly higher relative to the control group. Further, 
CAD-R is more likely to be associated with ARHI, but not 
vertigo-and-dizziness, even after adjusting for the com-
mon risk factors. This suggests that ARHI in CAD-R pa-
tients is not solely due to their age but might be explained 
by a concomitant CAD-R. 
ARHI is one of the most common conditions affecting 
older and elderly adults. It affects about 30% of people 
over 65 years of age and 50% of those over 80 years of 
age [22]. Because of the changes in the auditory system; 
the early onset of ARHI is often associated with tinnitus. 
However, beyond the aging effects, we believe that a sud-
den onset of bilateral tinnitus followed by hearing changes 
might be related to the global decline in vascular health in 
CAD-R patients. In support, a study found that the pres-
ence of carotid artery plaque and a 0.2 mm difference in 
carotid intima-media thickness in a predominantly mid-
dle-aged cohort is associated with an increased risk of in-
cident hearing loss (Odds Ratio was 1.18) [23]. Importantly, 
this difference in carotid intima-media thickness is similar 
to what is seen with five years of aging. 
Further, peripheral signs of the ARHI include the on-
ly-high-frequency hearing loss or high- and low-frequency 
hearing loss. The central symptoms include communica-
tive/perceptual difficulties, environmental sound detection 
difficulty, sound localization difficulty, and understanding 
spoken speech in quiet, in noise, over distances difficul-
ty. Although age is the main contributory factor to the 
progression of ARHL and central symptoms, there is evi-
dence that CAD can account for the abnormal audiologic 
findings - i.e., high-frequency hearing loss and central 
changes within the auditory brainstem pathways (inferior 
colliculus, superior Olivery nucleus, and cochlear nucle-
us complex) [19]. Importantly, these central changes may 
mimic the impact of stroke on all levels of the auditory 
pathway [24-27].
Several types of ARHI have been reported [28]. Senso-
ry presbycusis refers to loss (atrophy) of the outer hair 
cells in the organ of Corti that produces nerve impulses 
in response to sound vibrations. With sensory presbycu-
sis, which is slowly progressive and starts in mid-life, 
there is a sharp high-frequency sounds with relatively 
intact speech discrimination. Neural presbycusis, which 
begins early in life and effects are not noticeable until an 
older age, there is a disproportionately severe decrease 
in speech discrimination ability compared to their level 
DOI: https://doi.org/10.30564/jgm.v2i3.2385
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of hearing loss. Metabolic or stria presbycusis, which 
tends to occur in the last two to three decades of life with 
a slow progressive nature, the hearing loss represented 
by a high- and low-frequency hearing loss (meaning the 
entire cochlea is affected results from atrophy of the stria 
vascularis.) However, speech discrimination is preserved. 
Accordingly, the ARHI in CAD-R patients is not solely 
due to their age but might be explained by a concomitant 
CAD-R pathology. 
With regards to the recurrent positional vertigo and 
persistent dizziness with normal objective vestibular test-
ing in the CAD-R pateints, this can imply a functional 
dizziness or space and motion discomfort, which is the is 
the new term for somatoform or psychogenic dizziness. 
This results is consisnt with a previous study showed 
that carotid plaque is a new risk factor for peripheral 
vestibular disorder [29]. The high prevelane of functional 
dizziness in CAD-R pateints could be related to a history 
of peripheral vestibular disorders (i.e., benign paroxysmal 
positional vertigo) as many patients may complain of re-
sidual dizziness even after successful treatment [30-32]. Also, 
functional dizziness could an adverse effects of CAD-R 
on brain functions that can impair harmony between the 
vestibular (balance) functions and brain area known for 
its role in orientation, navigation, and maintenance of 
postural control in space [11-13]. It is well accepted that this 
pathophysiologic process in dizzy pateints with vascular 
risk factros seem to include precipitating events that trig-
ger anxiety-related changes in postural strategies with an 
increased attention to head and body motion and a cocon-
traction of leg muscles. Early diagnosis and management 
of functional dizziness, whethere it is secondary disorder 
after a peripheral or central changes syndrome, is very im-
portant to prevent further chronification and substantially 
reduce morbidity.
With that follows, the new task for the otorhinolaryn-
gological physician and audiologists is to impart the main 
statements to other healthcare providers (particularly to 
internists of cardiovascular physicians and neurologists) 
and verse versa. This can be done by developing a scoring 
system for the association of the CAD-R with InEarDs 
by combining the audiological-vestibular evaluation with 
the vascular assessments [20-21]. Such a system is currently 
lacking and requires further studies to validate and imple-
mented in clinical practice. 
Limitations 
Limitations of this study include its retrospective nature, 
for this may lead to a selection bias. Another potential 
limitation of this study is the use of two separate vascu-
lar patient databases with different inclusion time frames 
for the carotid and control groups. However, the use of a 
more recent database for the control group allowed for a 
more accurate exclusion of patients with carotid disease 
due to more precise imaging with more knowledge in the 
field, for this was our primary independent variable. The 
other limitation is related to the considerable number of 
patients who did not visit the hearing healthcare facility 
as compared to a number of patients who had visited the 
Audiology clinic. Information about the neurobehavioral 
assessments, including the neuroimaging in CAD-R pa-
tients, was lacking. 
5. Conclusion
CAD-R patients had significantly higher InEarDs than the 
control group. CAD-R is more likely to be associated with 
ARHI rather than the vertigo-and-dizziness even after ad-
justing for the vascular risk factors. Developing a scoring 
system for the association of the CAD-R with InEarDs is 
the next wise step if we are aiming to improve outcomes.
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